ArticleFrontiers in digital health2026
Lightweight structure-aware explanations for rule-based models: application to radiotherapy risk communication in breast cancer.
Article in Frontiers in digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Rule-based models are often considered inherently interpretable because their explicit logical structure allows users to trace predictions back to human-readable rules. However, in complex domains such as healthcare, multiple rules involving numerous attributes may be activated simultaneously, making it difficult for end users to identify the most influential factors behind a prediction. This can limit practical transparency, particularly in clinical shared decision-making, where clear and trustworthy explanations are essential. An example is communicating the risk of side effects following radiotherapy for breast cancer, where understanding the determinants of estimated risk may support informed treatment choices. Method: We propose a lightweight, structure-aware attribution method for rule-based models inspired by information retrieval techniques. The approach represents the activated rules associated with a prediction as a document-like structure and applies a TF-IDF-inspired weighting scheme to estimate the relevance of individual input attributes. Unlike perturbation-based methods such as SHAP and LIME, the proposed approach operates directly on the internal model structure, without requiring input perturbations, surrogate models, repeated evaluations, or access to training data. This preserves the explanatory signal encoded in the rules while reducing computational complexity and execution time. The method is evaluated through a technical comparison with SHAP and LIME and a user-centered study involving potential end users. Results and Conclusions: Experimental results show moderate agreement between the TF-IDF-inspired ranking and established attribution methods, identifying attributes that are behaviorally informative with respect to the implemented predictor. Faithfulness analysis shows that direct rule frequency achieves higher perturbation faithfulness, highlighting a trade-off introduced by the proposed weighting scheme. Complementarily, the user study indicates that the complete explanation pipeline, combining relevance weighting, semantic aggregation, and user-oriented presentation, is perceived as more interpretable and useful than raw rule-based explanations. These findings suggest that information-retrieval-inspired weighting can provide a lightweight mechanism for organizing rule evidence, while semantic abstraction and user-oriented presentation can facilitate its communication to end users.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.